Cardiometabolic Beat Podcast

Watch Drs. Tsimikas, Aleppo, and Shah discuss the benefits of digital interventions, including CGMs while managing people with diabetes. (Recorded October 18, 2023)

Watch Dr. Seth Martin, MD, MHS, discussing the significance of the role of technology and digital health in cardiometabolic risk reduction. (Recorded October 18, 2023)

Watch Drs. Ryan and Still discuss the pros and cons of both pharmacotherapy and bariatric surgery while managing people with obesity. (Recorded October 19, 2023)

Watch as CMHC Faculty Pam Taub MD and Ajay Singh MD recapped cardio-renal session at CMHC Annual 2023, where they discussed how cardiologists and nephrologists can work together to tackle cardio-renal diseases, including the latest cardio-renal therapies. (Recorded October 21, 2023)

Watch as CMHC Faculty Christie Ballantyne, MD, Robert Eckel, MD, Erin Michos, MD, Patrick Moriarty, MD, and Paul Ridker, MD, discuss practical pearls about the spectrum of residual ASCVD risk, including: Inflammation Statin intolerance Elevated triglycerides Lp(a)    Recorded October 20, 2023

Watch CMHC Faculty Francoise Marvel, MD and Daichi Shimbo, MD discuss challenges and practical pearls for the use of digital health technologies, focusing on remote blood pressure monitoring and telehealth visits (recorded October 18, 2023).

Watch as CMHC faculty Juan Frías, MD and Shivani Agarwal, MD discuss important pearls in the management of type 2 diabetes, including screening for social determinants of health (SDOH), the impact of SDOH on treatment, culturally-sensitive care, as well as the importance of early glycemic control, screening, and GDMT optimization (recorded October 20, 2023).

Watch as CMHC faculty Christie Ballantyne, MD, Robert Eckel, MD, Keith Ferdinand, MD, and Anne Peters, MD recap some of the main developments in 2023 across the cardio-renal-metabolic health as discussed at the 18th CMHC Annual meeting, including in obesity, diabetes, dyslipidemia/ASCVD risk, hypertension, and more (recorded October 19, 2023).

Watch CMHC co-chairs Christie Ballantyne, MD and Robert Eckel, MD discuss the connections between cardio-renal-metabolic health, and the value of attending the CMCH Annual meeting (recorded October 2023).

Vanita Aroda, MD, Associate Professor of Medicine at Harvard Medical School, and Katherine Tuttle, MD, Professor of Medicine at the University of Washington, discuss current disparities in the treatment of women with type 2 diabetes and cardiorenal risk despite the evidence and breadth of available agents. They discuss that women are less likely to receive guideline-directed medical therapy, including both older and newer agents, and less likely to enroll in clinical trials, as well as the need to recognize and address these disparities.   Recorded during 2023 CMHC's Women's Health Masterclass, August 19, 2023.